Table 3.
Outcome | Group | Baseline | 5 weeks | 13 weeks | ||||
---|---|---|---|---|---|---|---|---|
Mean (SD) | Mean (SD) | P a | LSMD (95 % CI)a | Mean (SD) | P a | LSMD (95 % CI)a | ||
FSS | A | 4.67 (1.27) | 3.39 (1.12) | <0.001 | −1.14 (−1.57, −0.71) | 3.32 (1.17) | <0.001 | −1.01 (−1.48, −0.55) |
B | 4.75 (1.07) | 3.62 (1.13) | <0.001 | −0.95 (−1.38, −0.52) | 3.58 (1.20) | <0.001 | −0.80 (−1.26, −0.34) | |
C | 4.48 (1.27) | 4.43 (1.19) | - | - | 4.24 (1.25) | - | - | |
SRI-short form | A | 62.56 (17.95) | 43.07 (15.49) | <0.001 | −15.24 (−21.32, −9.16) | 43.61 (15.31) | <0.001 | −15.01 (−21.96, −8.06) |
B | 55.67 (14.40) | 42.65 (14.24) | <0.001 | −11.58 (−17.45, −5.72) | 40.19 (13.57) | <0.001 | −14.97 (−21.67, −8.26) | |
C | 60.04 (18.16) | 56.82 (18.10) | - | - | 57.36 (20.30) | - | - | |
BDI | A | 16.41 (8.36) | 9.43 (6.98) | <0.001 | −5.03 (−7.60, −2.47) | 10.02 (6.40) | <0.001 | −4.74 (−7.56, −1.91) |
B | 15.00 (7.67) | 9.04 (7.61) | <0.001 | −4.63 (−7.17, −2.10) | 8.20 (7.01) | <0.001 | −5.88 (−8.67, −3.09) | |
C | 15.30 (7.05) | 13.84 (6.80) | - | - | 14.22 (8.32) | - | - | |
NRS | A | 6.59 (1.44) | 4.56 (2.09) | <0.001 | −1.96 (−2.72, −1.20) | 4.78 (2.32) | <0.001 | −1.64 (−2.51, −0.78) |
B | 6.55 (1.27) | 4.58 (1.70) | <0.001 | −1.93 (−2.68, −1.18) | 4.59 (1.92) | <0.001 | −1.81 (−2.67, −0.96) | |
C | 6.40 (1.40) | 6.46 (1.39) | - | - | 6.34 (1.70) | - | - | |
EQ-5D | A | 0.84 (0.10) | 0.96 (0.11) | 0.025 | 0.04 (0.00, 0.08) | 0.91 (0.11) | 0.008 | 0.06 (0.01, 0.11) |
B | 0.87 (0.09) | 0.91 (0.09) | 0.107 | 0.03 (−0.01, 0.07) | 0.93 (0.09) | 0.005 | 0.06 (0.02, 0.11) | |
C | 0.88 (0.11) | 0.88 (0.09) | - | - | 0.87 (0.15) | - | - |
LSMD, least squares mean difference; CI, confidence interval; FSS, fatigue severity scale; SRI-short form, short form of the stress response inventory; BDI, Beck depression inventory; NRS, numeric rating scale; EQ-5D, EuroQol-5 dimension
a P value with 95 % CI, Dunnett’s adjustment